First experience of durable cytoreduction in chronic lymphoid leukemia with (177)Lu-DOTATATE.

Détails

Demande d'une copieDemande d'une copie
ID Serval
serval:BIB_07D092E4020F
Type
Article: article d'un périodique ou d'un magazine.
Sous-type
Etude de cas (case report): rapporte une observation et la commente brièvement.
Collection
Publications
Institution
UNIL/CHUV
Titre
First experience of durable cytoreduction in chronic lymphoid leukemia with (177)Lu-DOTATATE.
Périodique
Medical oncology
Auteur⸱e⸱s
Savovic T., Prior J.O., Nicod-Lalonde M., Bressoud A., Roux S., Schaefer N., Meyer M.
ISSN
1559-131X (Electronic)
ISSN-L
1357-0560
Statut éditorial
Publié
Date de publication
27/03/2019
Peer-reviewed
Oui
Volume
36
Numéro
5
Pages
41
Langue
anglais
Notes
Publication types: Case Reports ; Journal Article
Publication Status: epublish
Résumé
This is the first described case of effective and durable cytoreduction after PRRT with <sup>177</sup> Lu-DOTATATE in a 75-year-old female, with B cell chronic lymphoid leukemia, and well-differentiated metastatic neuroendocrine tumor.
Mots-clé
Aged, Antineoplastic Agents/therapeutic use, Cytoreduction Surgical Procedures/methods, Dose-Response Relationship, Drug, Drug Administration Schedule, Female, Humans, Leukemia, Lymphocytic, Chronic, B-Cell/drug therapy, Leukemia, Lymphocytic, Chronic, B-Cell/pathology, Liver Neoplasms/drug therapy, Liver Neoplasms/radiotherapy, Liver Neoplasms/secondary, Neuroendocrine Tumors/drug therapy, Neuroendocrine Tumors/radiotherapy, Neuroendocrine Tumors/secondary, Octreotide/analogs & derivatives, Octreotide/therapeutic use, Organometallic Compounds/therapeutic use, Treatment Outcome, 117Lu-DOTATATE, Chronic lymphoid leukemia, Neuroendocrine tumor, PET/CT, PRRT
OAI-PMH
oai:serval.unil.ch:BIB_07D092E4020F
DOI
10.1007/s12032-019-1266-0
Pubmed
30919094
Web of science
000462937600003
Création de la notice
15/04/2019 9:55
Dernière modification de la notice
11/09/2019 10:49
Données d'usage